Avidity Partners Management LP - Q1 2022 holdings

$4.8 Billion is the total value of Avidity Partners Management LP's 92 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 46.4% .

 Value Shares↓ Weighting
NewSPDR SER TRcall$296,604,0003,300,000
+100.0%
6.18%
AZN BuyASTRAZENECA PLCsponsored adr$245,458,000
+47.0%
3,700,000
+29.0%
5.11%
+44.3%
ABBV SellABBVIE INC$237,669,000
-11.6%
1,466,100
-26.1%
4.95%
-13.2%
ANTM BuyANTHEM INC$196,193,000
+31.9%
399,400
+24.4%
4.08%
+29.4%
ARVN BuyARVINAS INC$196,200,000
-5.5%
2,915,300
+15.3%
4.08%
-7.2%
MRK NewMERCK & CO INC$194,459,0002,370,000
+100.0%
4.05%
AVTR BuyAVANTOR INC$191,702,000
-5.1%
5,668,300
+18.3%
3.99%
-6.8%
BAX BuyBAXTER INTL INC$148,528,000
-2.0%
1,915,500
+8.5%
3.09%
-3.7%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$146,587,000
-35.8%
3,176,999
+17.0%
3.05%
-36.9%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$145,960,000
-7.1%
1,231,000
+8.0%
3.04%
-8.8%
VRTX BuyVERTEX PHARMACEUTICALS$142,385,000
+131.6%
545,600
+94.9%
2.96%
+127.4%
UNH BuyUNITEDHEALTH GROUP INC$132,388,000
+114.2%
259,600
+110.9%
2.76%
+110.3%
UTHR BuyUNITED THERAPEUTICS CORP DEL$128,986,000
+11.6%
718,946
+34.4%
2.69%
+9.5%
HZNP BuyHORIZON THERAPEUTICS PUB L$119,035,000
+9.2%
1,131,400
+11.8%
2.48%
+7.2%
MRTX BuyMIRATI THERAPEUTICS INC$114,532,000
-3.2%
1,393,000
+72.7%
2.38%
-4.9%
ISEE SellIVERIC BIO INC$108,981,000
-6.3%
6,475,400
-6.9%
2.27%
-8.0%
NBIX SellNEUROCRINE BIOSCIENCES INC$108,750,000
+1.3%
1,160,000
-7.9%
2.26%
-0.5%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$100,620,000
+39.4%
6,043,219
+59.9%
2.10%
+36.9%
ISRG NewINTUITIVE SURGICAL INC$98,046,000325,000
+100.0%
2.04%
CTLT BuyCATALENT INC$86,724,000
-2.5%
782,000
+12.5%
1.81%
-4.3%
HUM NewHUMANA INC$86,555,000198,900
+100.0%
1.80%
SNDX  SYNDAX PHARMACEUTICALS INC$83,831,000
-20.6%
4,823,4000.0%1.75%
-22.0%
BIIB NewBIOGEN INC$76,869,000365,000
+100.0%
1.60%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$63,107,000
+7.2%
869,000
+24.1%
1.31%
+5.3%
JNJ NewJOHNSON & JOHNSON$62,739,000354,000
+100.0%
1.31%
ACET BuyADICET BIO INC$62,306,000
+17.4%
3,120,000
+2.8%
1.30%
+15.3%
KZR BuyKEZAR LIFE SCIENCES INC$58,469,000
+8.3%
3,518,000
+9.0%
1.22%
+6.3%
MCK NewMCKESSON CORP$58,012,000189,500
+100.0%
1.21%
ARGX NewARGENX SEsponsored adr$55,495,000176,000
+100.0%
1.16%
BSX NewBOSTON SCIENTIFIC CORP$52,975,0001,196,100
+100.0%
1.10%
NTRA BuyNATERA INC$52,884,000
-39.8%
1,300,000
+38.3%
1.10%
-40.9%
EW NewEDWARDS LIFESCIENCES CORP$51,797,000440,000
+100.0%
1.08%
ARWR BuyARROWHEAD PHARMACEUTICALS IN$43,920,000
-24.3%
955,000
+9.1%
0.91%
-25.7%
IMCR BuyIMMUNOCORE HLDGS PLCads$40,778,000
-3.2%
1,363,800
+10.9%
0.85%
-4.9%
LEGN BuyLEGEND BIOTECH CORPsponsored ads$39,792,000
+19.9%
1,095,000
+53.8%
0.83%
+17.8%
XBI NewSPDR SER TRs&p biotech$39,547,000440,000
+100.0%
0.82%
BHC NewBAUSCH HEALTH COS INC$38,724,0001,694,700
+100.0%
0.81%
RNA BuyAVIDITY BIOSCIENCES INC$37,771,000
-12.5%
2,045,000
+12.7%
0.79%
-14.1%
INSM SellINSMED INC$31,832,000
-19.4%
1,354,539
-6.6%
0.66%
-20.9%
ATEC SellALPHATEC HLDGS INC$31,459,000
-0.7%
2,735,600
-1.3%
0.66%
-2.5%
IDYA BuyIDEAYA BIOSCIENCES INC$30,101,000
-50.1%
2,690,000
+5.4%
0.63%
-51.0%
AXSM SellAXSOME THERAPEUTICS INC$29,428,000
+0.5%
711,000
-8.3%
0.61%
-1.3%
CCXI BuyCHEMOCENTRYX INC$29,457,000
+25.5%
1,175,000
+82.3%
0.61%
+23.1%
RCUS NewARCUS BIOSCIENCES INC$28,783,000912,000
+100.0%
0.60%
NTLA NewINTELLIA THERAPEUTICS INC$28,347,000390,075
+100.0%
0.59%
PHAT BuyPHATHOM PHARMACEUTICALS INC$26,485,000
-29.0%
1,946,000
+2.6%
0.55%
-30.3%
BuyCARIBOU BIOSCIENCES INC$25,879,000
-35.9%
2,819,067
+5.4%
0.54%
-37.0%
NUVB SellNUVATION BIO INC$25,537,000
-59.3%
4,855,006
-34.2%
0.53%
-60.0%
BLU SellBELLUS HEALTH INC NEW$25,353,000
-16.6%
3,685,000
-2.4%
0.53%
-18.1%
SPNE  SEASPINE HLDGS CORP$24,442,000
-10.7%
2,010,0000.0%0.51%
-12.4%
PEN NewPENUMBRA INC$23,102,000104,000
+100.0%
0.48%
SIBN BuySI-BONE INC$22,600,000
+3.1%
1,000,000
+1.3%
0.47%
+1.3%
VIR BuyVIR BIOTECHNOLOGY INC$20,062,000
-31.6%
780,000
+11.4%
0.42%
-32.8%
VRDN SellVIRIDIAN THERAPEUTICS INC$19,230,000
-23.9%
1,040,000
-18.6%
0.40%
-25.4%
BPMC SellBLUEPRINT MEDICINES CORP$18,601,000
-82.5%
291,184
-70.7%
0.39%
-82.9%
ALT BuyALTIMMUNE INC$17,448,000
-31.1%
2,865,000
+3.6%
0.36%
-32.4%
EPIX  ESSA PHARMA INC$15,203,000
-56.5%
2,460,0000.0%0.32%
-57.2%
SGEN SellSEAGEN INC$14,405,000
-86.4%
100,000
-85.4%
0.30%
-86.6%
GLPG NewGALAPAGOS NVspon adr$13,334,000215,000
+100.0%
0.28%
IPSC BuyCENTURY THERAPEUTICS INC$10,890,000
-19.4%
865,000
+1.6%
0.23%
-20.6%
ALPN SellALPINE IMMUNE SCIENCES INC$10,827,000
-41.9%
1,207,000
-10.3%
0.22%
-43.0%
APLS NewAPELLIS PHARMACEUTICALS INC$10,670,000210,000
+100.0%
0.22%
NewAN2 THERAPEUTICS INC$10,373,000688,330
+100.0%
0.22%
NewERASCA INC$8,557,000995,000
+100.0%
0.18%
S SellSENTINELONE INCcl a$7,922,000
-24.6%
204,500
-1.7%
0.16%
-26.0%
CYT BuyCYTEIR THERAPEUTICS INC$6,975,000
-66.8%
1,850,000
+0.0%
0.14%
-67.5%
PHAS  PHASEBIO PHARMACEUTICALS INC$5,815,000
-49.4%
4,405,0000.0%0.12%
-50.4%
CMAX SellCAREMAX INC$5,642,000
-11.2%
755,329
-8.7%
0.12%
-13.3%
BuyTANGO THERAPEUTICS INC$5,465,000
-29.1%
721,000
+2.3%
0.11%
-30.5%
SellHYPERFINE INC$5,323,000
-51.5%
1,503,754
-0.7%
0.11%
-52.4%
MSAC  MEDICUS SCIENCES ACQUISITION$5,086,000
+0.9%
520,0000.0%0.11%
-0.9%
BLSA  BCLS ACQUISITION CORP$4,935,000
+0.7%
500,0000.0%0.10%
-1.0%
DYNS  DYNAMICS SPECIAL PURPOSE COR$4,935,000
+0.1%
500,0000.0%0.10%
-1.9%
ARYD  ARYA SCIENCES ACQU CORP IVcl a$4,900,000
-1.2%
500,0000.0%0.10%
-2.9%
PANA  PANACEA ACQUISITION CORP II$4,875,000
+0.5%
500,0000.0%0.10%
-1.0%
HLXA  HELIX ACQUISITION CORP$4,440,000
+12.2%
400,0000.0%0.09%
+9.5%
HSAQ  HEALTH SCIENCES ACQ CORP 2$3,964,000
-1.7%
400,0000.0%0.08%
-3.5%
SellFIELD TRIP HEALTH LTD$3,988,000
-49.4%
2,976,000
-7.1%
0.08%
-50.3%
GRPH  GRAPHITE BIO INC$3,621,000
-59.0%
710,0000.0%0.08%
-59.9%
ONCS  ONCOSEC MED INC$3,387,000
+19.9%
2,945,0000.0%0.07%
+18.3%
OTIC NewOTONOMY INC$3,240,0001,349,905
+100.0%
0.07%
 SEMA4 HOLDINGS CORP$2,917,000
-31.2%
950,0000.0%0.06%
-32.2%
CMPX  COMPASS THERAPEUTICS INC$2,740,000
-56.8%
2,000,0000.0%0.06%
-57.5%
GRTS SellGRITSTONE BIO INC$2,307,000
-95.9%
560,000
-87.2%
0.05%
-96.0%
BuySCIENCE 37 HOLDINGS INC$2,301,000
-53.2%
430,000
+9.1%
0.05%
-53.8%
SCYX SellSCYNEXIS INC$2,127,000
-84.4%
544,043
-75.7%
0.04%
-84.8%
DNAA  SOCIAL CAP SUVRETTA HLDS CRP$1,978,000
-0.4%
200,0000.0%0.04%
-2.4%
DNAB  SOCIAL CAP SUVRETTA HLDS CRP$1,950,000
-1.4%
200,0000.0%0.04%
-2.4%
DNAC  SOCIAL CAP SUVRETTA HLD CRPI$1,980,0000.0%200,0000.0%0.04%
-2.4%
DNAD  SOCIAL CAP SUVRETTA HLDS CP$1,948,000
-0.8%
200,0000.0%0.04%
-2.4%
NUVBWS  NUVATION BIO INC*w exp 07/07/202$76,000
-59.8%
99,9990.0%0.00%
-50.0%
MSACW  MEDICUS SCIENCES ACQUISITION*w exp 02/12/202$25,000
-40.5%
57,7700.0%0.00%0.0%
ExitSOMALOGIC INC*w exp 08/31/202$0-65,999
-100.0%
-0.01%
ZIOP ExitZIOPHARM ONCOLOGY INC$0-590,000
-100.0%
-0.01%
STTK ExitSHATTUCK LABS INC$0-165,000
-100.0%
-0.03%
MRUS ExitMERUS N V$0-103,000
-100.0%
-0.07%
ExitSOMALOGIC INC$0-330,000
-100.0%
-0.08%
ExitENTRADA THERAPEUTICS INC$0-255,000
-100.0%
-0.09%
HOWL ExitWEREWOLF THERAPEUTICS INC$0-485,000
-100.0%
-0.12%
GLUE ExitMONTE ROSA THERAPEUTICS INC$0-300,000
-100.0%
-0.13%
ExitEQRX INC$0-1,000,000
-100.0%
-0.14%
ExitDEFINITIVE HEALTHCARE CORP$0-250,000
-100.0%
-0.14%
TALS ExitTALARIS THERAPEUTICS INC$0-455,037
-100.0%
-0.15%
TIL ExitINSTIL BIO INC$0-408,140
-100.0%
-0.15%
ACAD ExitACADIA PHARMACEUTICALS INC$0-300,000
-100.0%
-0.15%
RLMD ExitRELMADA THERAPEUTICS INC$0-731,536
-100.0%
-0.35%
GBT ExitGLOBAL BLOOD THERAPEUTICS IN$0-862,000
-100.0%
-0.54%
AMN ExitAMN HEALTHCARE SVCS INC$0-280,100
-100.0%
-0.73%
OCDX ExitORTHO CLINICAL DIAGNOSTICS H$0-1,790,000
-100.0%
-0.81%
KYMR ExitKYMERA THERAPEUTICS INC$0-670,000
-100.0%
-0.90%
ExitSTEVANATO GROUP S P A$0-2,541,893
-100.0%
-1.21%
ALNY ExitALNYLAM PHARMACEUTICALS INC$0-370,000
-100.0%
-1.33%
SHC ExitSOTERA HEALTH CO$0-2,960,000
-100.0%
-1.48%
HOLX ExitHOLOGIC INC$0-1,064,000
-100.0%
-1.73%
LLY ExitLILLY ELI & CO$0-344,800
-100.0%
-2.02%
ARNA ExitARENA PHARMACEUTICALS INC$0-1,215,500
-100.0%
-2.40%
PFE ExitPFIZER INC$0-2,090,000
-100.0%
-2.62%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEUROCRINE BIOSCIENCES INC15Q3 20234.6%
ARVINAS INC14Q3 20234.9%
ZENTALIS PHARMACEUTICALS INC14Q3 20234.8%
SYNDAX PHARMACEUTICALS INC14Q3 20233.2%
IDEAYA BIOSCIENCES INC13Q3 20232.5%
NATERA INC13Q3 20231.9%
ALPINE IMMUNE SCIENCES INC13Q3 20230.5%
ABBVIE INC12Q2 20239.7%
HORIZON THERAPEUTICS PUB LTD12Q3 20223.4%
AVANTOR INC11Q1 20236.0%

View Avidity Partners Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Avidity Partners Management LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Adicet Bio, Inc.Sold outFebruary 14, 202300.0%
ALPINE IMMUNE SCIENCES, INC.February 14, 20231,888,8874.0%
ESSA Pharma Inc.February 14, 20231,855,4004.2%
Gritstone bio, Inc.February 14, 20232,859,9713.3%
IVERIC bio, Inc.February 14, 2023838,4070.6%
ONCOSEC MEDICAL IncSold outFebruary 14, 202300.0%
PhaseBio Pharmaceuticals IncFebruary 14, 20232,040,0004.1%
Phathom Pharmaceuticals, Inc.February 14, 20231,900,0004.6%
Viridian Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Anika Therapeutics, Inc.Sold outFebruary 14, 202200.0%

View Avidity Partners Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-27
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View Avidity Partners Management LP's complete filings history.

Compare quarters

Export Avidity Partners Management LP's holdings